New Enterprise Associates
Investor profile
Investment firmVenture capital
Deals
49
distinct rounds
Companies
34
backed
Active span
2008–2025
18 yrs
Total round €
€1.3B
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- e.ventures4
- Gilde Healthcare4
- Notion Capital4
- Accel3
- HV Holtzbrinck Ventures3
- Index Ventures3
- Marker LLC3
- Runa Capital3
- Sequoia Capital3
- Andreessen Horowitz2
- Asabys Partners2
- Battery Ventures2
- Bessemer Venture Partners2
- Cervin Ventures2
- Citi2
- GIMV2
- Hasso Plattner Ventures2
- Innovation Endeavors2
- Insight Partners2
- Lakestar2
- Lightstone Ventures2
- Medtronic2
- Naspers2
- Novartis Venture Fund2
- Novo Holdings2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Letgo | Spain | 2 | €250M |
| SpliceBio | Spain | 2 | €168M |
| Adaptimmune | UK | 1 | €95M |
| MOVE Guides | UK | 4 | €67M |
| GoEuro | Germany | 2 | €65M |
| Fire1 | Ireland | 2 | €64M |
| CRISPR Therapeutics | Switzerland | 1 | €58M |
| ObsEva | Switzerland | 1 | €55M |
| Forter | Israel | 2 | €43M |
| Nightstar | UK | 1 | €41M |
| Nginx | Russia | 3 | €35M |
| AddThis | Austria | 2 | €35M |
| NightstaRx | UK | 1 | €32M |
| Boku | Germany | 1 | €32M |
| Therachon | France | 1 | €32M |
| Yubico | Sweden | 1 | €27M |
| CCP Games | Iceland | 1 | €27M |
| illusive Networks | Israel | 2 | €23M |
| Frontier | Finland | 1 | €20M |
| Polyneuron Pharmaceuticals AG | Switzerland | 1 | €19M |
| payleven | Germany | 2 | €19M |
| Attest | UK | 1 | €14M |
| Interlude | Israel | 1 | €14M |
| GRID | Iceland | 1 | €10M |
| CupoNation | Germany | 1 | €10M |
| Folloze | Israel | 2 | €9.6M |
| Aquabyte | Norway | 1 | €8.6M |
| Superb | Italy | 1 | €7.1M |
| DJUST | France | 1 | €7.0M |
| Konux | Germany | 1 | €6.8M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Letgo | Series C | €159M | 2016-12 |
| SpliceBio | Series B | €118M | 2025-06 |
| Adaptimmune | Series A | €95M | 2014-08 |
| Letgo | Series B | €91M | 2016-04 |
| CRISPR Therapeutics | Series B | €58M | 2015-03 |
| ObsEva | Series B | €55M | 2015-10 |
| SpliceBio | Series A | €50M | 2022-02 |
| MOVE Guides | Series C | €44M | 2017-08 |
| Nightstar | Series C | €41M | 2017-07 |
| GoEuro | Series B | €41M | 2015-11 |